Solid Tumor

Showing NaN - NaN of 49

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Solid Tumor Trial in United States (PLX3397)

Completed
  • Solid Tumor
  • Scottsdale, Arizona
  • +12 more
Dec 6, 2021

Solid Tumor, Unresectable or Metastatic Melanoma Trial in Worldwide (CX-072, Ipilimumab)

Terminated
  • Solid Tumor
  • Unresectable or Metastatic Melanoma
  • Duarte, California
  • +26 more
Nov 2, 2021

Solid Tumor Trial in Belgium, Japan, United States (LY3415244)

Terminated
  • Solid Tumor
  • Boston, Massachusetts
  • +5 more
Oct 21, 2021

Subjects Treated With ACTR T Cell Product

Terminated
  • B Cell Lymphomas
  • +3 more
  • ACTR T Cell Product
  • Gilbert, Arizona
  • +15 more
Oct 4, 2021

Solid Tumor Trial in Boston, Buffalo, San Antonio (Oraxol)

Completed
  • Solid Tumor
  • Boston, Massachusetts
  • +2 more
Sep 6, 2021

Solid Tumor Trial in Worldwide (LY3321367, LY3300054)

Active, not recruiting
  • Solid Tumor
  • Tucson, Arizona
  • +14 more
Sep 2, 2021

Solid Tumor Trial in Boston (Prexasertib, Olaparib)

Completed
  • Solid Tumor
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 1, 2021

Solid Tumor Trial in Korea, Republic of, United States (RMC-4630, Cobimetinib, Drug: Osimertinib)

Active, not recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +23 more
Aug 31, 2021

Solid Tumor Trial in Worldwide (5-FU, Atezolizumab, Bevacizumab)

Completed
  • Solid Tumor
  • Palo Alto, California
  • +29 more
Jul 8, 2021

Solid Tumor, Melanoma, NSCLC Trial in Australia, United States (T3011, T3011 + pembrolizumab)

Recruiting
  • Solid Tumor
  • +2 more
  • T3011
  • T3011 + pembrolizumab
  • Gilbert, Arizona
  • +7 more
Jun 22, 2021

Solid Tumor, Solid Tumor Trial in Worldwide (BEZ235 + MEK162)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Solid Tumor
  • BEZ235 + MEK162
  • Boston, Massachusetts
  • +5 more
Oct 7, 2020

Solid Tumor, Lymphoma, Peripheral T-Cell Lymphoma Trial in United States (ALRN-6924)

Completed
  • Solid Tumor
  • +2 more
  • Birmingham, Alabama
  • +12 more
Jul 13, 2020

Solid Tumor Trial in Worldwide (Atezolizumab)

Terminated
  • Solid Tumor
  • Little Rock, Arkansas
  • +29 more
Feb 24, 2020

Solid Tumor Trial in Worldwide (Atezolizumab, GDC-0919)

Completed
  • Solid Tumor
  • Scottsdale, Arizona
  • +17 more
Oct 18, 2019

Solid Tumor, Kidney Cancer Trial in Boston (pazopanib, everolimus)

Completed
  • Solid Tumor
  • Kidney Cancer
  • Boston, Massachusetts
  • +1 more
Sep 18, 2019

Solid Tumor Trial in Boston (Capecitabine, 5-Fluorouracil (5-FU), Irinotecan)

Completed
  • Solid Tumor
  • Boston, Massachusetts
  • +2 more
Oct 31, 2018

Solid Tumor, Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations, Tenosynovial Giant Cell Tumor

Terminated
  • Solid Tumor
  • +2 more
  • PLX7486 TsOH
  • Los Angeles, California
  • +3 more
Aug 1, 2018

Solid Tumor, Liver Metastases Trial in Boston (Stereotactic body radiotherapy-proton)

Completed
  • Solid Tumor
  • Liver Metastases
  • Stereotactic body radiotherapy-proton
  • Boston, Massachusetts
  • +1 more
Oct 3, 2017

Solid Tumor Trial in Boston (BAY 1000394)

Withdrawn
  • Solid Tumor
  • BAY 1000394
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 29, 2016

Sarcoma, Solid Tumor Trial in Boston (RAD001, CP-751,871)

Completed
  • Sarcoma
  • Solid Tumor
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 12, 2013

Solid Tumor Trial in Boston (Taxotere, Cisplatin, CPT-11)

Completed
  • Solid Tumor
  • Boston, Massachusetts
  • +2 more
Aug 7, 2012